Overview

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This study is a Randomized Phase II Study to Compare Efficacy of CHOP versus Fractionated ICED in Transplant-eligible Patients with Previously Untreated Peripheral T-cell Lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Carboplatin
Cyclophosphamide
Dexamethasone
Etoposide
Ifosfamide
Prednisone
Vincristine